Peng Wei

6PUBLICATIONS
37CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2026
Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections.

|Jun 17, 2026
ADAR1 Deficiency in Pancreatic Cancer Cells Potentiates cDC1 Activation and Promotes Sensitization to Immunotherapy.

|Feb 06, 2026
Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Birui Pan, Qinli Sun, Ruifeng Li

|Nov 13, 2025
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.

Bowen Xie, Bowen Yuan, Xiaohong Zhao

|Oct 20, 2023
BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1.

Qinli Sun, Dongli Cai, Dingfeng Liu

|Jan 23, 2023
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection.

Qinli Sun, Xiaohong Zhao, Ruifeng Li

Pageof 1

Frequent Collaborators

6 joint publications

Bowen Xie

6 joint publications

Chen Dong

5 joint publications

Qinli Sun

3 joint publications

Yongzhen Chen